1. medical ethics and informed consent: when the subject of the thesis is human, the author should provide the approval documents of the ethics Committee of the unit, region or country and the informed consent of the subject or his relatives.
2. Fund projects: If the topic involved in the paper is a national or ministerial fund or a key project above the provincial level, it should be indicated in the lower left corner of the first page of the article, such as "Fund project: National Natural Science Foundation of China (30271269)"; Tenth Five-year Plan for National High-tech Research and Development (2003AA205005) ". A copy of the fund project certificate shall be attached.
3. Title: Try to be concise and eye-catching and accurately reflect the theme of the article. Generally speaking, Chinese titles should be less than 20 Chinese characters, and it is best not to have subtitles, punctuation marks and abbreviations. English titles should not exceed 10 notional words. Chinese and English titles should have the same meaning.
4. Author's signature: The author's names are arranged in order under the title, and the order should be determined before submission, and it cannot be changed during the arrangement. The name of the author's unit (write down the department) and postal code are marked on the lower left of the homepage, and the author of the communication and his e-mail address are also indicated. The author should be: (1) someone who has participated in topic selection and design, or in material analysis and interpretation; (2) Drafting or revising key theories or other main contents in the paper; (3) Be able to revise the editorial department's revision opinions, make a defense in the academic circles, and finally agree with the publisher of this article. The above three items must be met at the same time. Those who only participate in obtaining funds or collecting data cannot be listed as authors, nor should the general manager who only conducts scientific research groups be listed as authors. At least 1 The author must be responsible for all the main conclusions in the article. If there is a foreign author among the authors, a letter signed by the foreign author agreeing to be published in this journal should be attached. Collectively signed articles should be signed by the unit below the title, and the name of the organizer should be listed at the end of the article, and the main person in charge of the article should be clearly defined, and the author's name, unit, postal code and e-mail address should be indicated in the footnote on the first page of the paper. General communication authors only list 1, which is decided by the contributor. If you need to indicate the members of the collaboration group, list the units and names of the members of the collaboration group before the references at the end of the article.
5. Abstract: The paper must be accompanied by a Chinese and English abstract, which should include four parts: purpose, method, result (main data should be given) and conclusion, and each part should have a corresponding title. Write in the third person, don't draw pictures, don't show, don't quote documents, don't comment, don't explain. The English abstract should include the title, author's name (Chinese pinyin), unit name, city name, postal code and country name. All authors should be listed by name. If the author's work unit is different, only the communication author's work unit is listed, with "*" in the upper right corner of the communication author's name and "*" in the upper left corner of the initials of the communication author's work unit. For example: "Lin Xianyan *, Wu Jianping, Qin Jian, Liu Hong. * Department of Pediatrics, Peking University First Hospital, Beijing, China 100034 ". Generally, the Chinese abstract does not exceed 400 Chinese characters, and the English abstract contains about 250 content words. English abstracts generally correspond to Chinese abstracts, but they can be refined for the needs of foreign exchange.
6. Keywords: 2~5 keywords should be indexed in the paper. Key words should be selected from the MeSH of the National Library of Medicine, and their Chinese translation can refer to the annotations of medical subject words compiled by the Institute of Information, China Academy of Medical Sciences. New technical terms (free words) that are not included in the glossary can be directly used as keywords, and suggestions are ranked last. Abbreviations in keywords should be restored to full names according to the list of medical subject words; The first word of each English keyword is capitalized and ";" It is used between words. Separate.
7. Research design: The name and main methods of the research design shall be informed. Such as survey design (divided into prospective, retrospective or cross-sectional survey research), experimental design (specific design types should be informed, such as self-paired design, grouping design, crossover design, factorial design, orthogonal design, etc. ), clinical trial design (which stage of clinical trial should be informed and what blind measures should be taken, etc.). ); The main methods should be outlined around four basic principles (repetition, randomness, contrast and balance), especially how to control the interference and influence of important non-experimental factors.
8. Statistical methods:
(1) Selection of statistical analysis methods: For quantitative data, data conditions and analysis purposes, appropriate statistical analysis methods should be selected, and T test and one-way ANOVA should not be blindly applied; For qualitative data, χ2 test should be used blindly according to the design type, the nature of qualitative variables, the conditions of occurrence frequency and the purpose of analysis. For regression analysis, we should combine professional knowledge and scatter plot to choose the appropriate regression type, and we should not blindly apply linear regression analysis; Regression analysis data with repeated experimental data should not be simplified; For multi-factor and multi-index data, on the basis of univariate analysis, multivariate statistical analysis method should be used as much as possible, so as to make a comprehensive and reasonable explanation and evaluation of the interaction between factors and the internal relationship between multi-indicators.
(2) Statistical symbols: written according to the relevant provisions of GB 3358- 1982 Statistical Terms and Symbols. Commonly used: ① The arithmetic mean of the sample is in English lowercase (the median is still in M); ② The standard deviation is in English lowercase s; ③ Standard misuse of English lowercase SX; ④ T-test with English lowercase t; ⑤F capitalized in English means F test; ⑤ 2 Greek is chi-square test; ⑦ correlation coefficient in English lowercase r; 8 degrees of freedom of Greek lowercase v; ⑨ Probability English should be capitalized (specific test values should be given before P value, such as T value, χ2 value, Q value, etc. ).
(3) Expression and description of data: χ s is used to express quantitative data which approximately obeys normal distribution, and M(QR) is used to express quantitative data which is skewed distribution; When using relative numbers, the denominator should not be less than 20, and attention should be paid to distinguishing percentages from percentages.
(4) Interpretation and expression of statistical results: When P
9. Terminology: Medical terminology should use the terminology published by the National Committee for the Examination and Approval of Scientific and Technical Terminology. Subject nouns that have not passed the examination and approval can be selected from the latest version of MeSH, notes on medical subject words and Chinese medicine subject words. When a noun term without a common translation appears for the first time in the text, the original word should be indicated. The names of Chinese and western medicines shall be subject to the latest edition of People's Republic of China (PRC) Pharmacopoeia and General Names of Drugs in China (both edited by China Pharmacopoeia Committee). English drug names adopt international drug names. In general, trade names are not allowed to be used for drug names. If it is really necessary to use a trade name, the common name should be indicated first.
Abbreviations are used as little as possible in this article. When it must be used, the full name should be stated first, and then the Chinese abbreviation or the English full name and abbreviation should be indicated in brackets. Well-known abbreviations can be used directly without comments, such as DNA, RNA, HBsAg, PCR, etc.
10. Charts: Each chart should have a title of the chart (table). Explanatory text should be placed in the notes below the figure (table), and all non-public abbreviations used in the figure should be indicated in the notes. It is recommended to use a table with three horizontal lines (top line, header line and bottom line). If there are total and statistical processing contents (such as t value and p value, etc. ), add a dividing line on this line; The data in the table requires the same number of significant digits of the same indicator. The data map and photo map should have good clarity and contrast, and the image map should be marked left and right; Where a portrait of a person is published, the written consent of the person shall be obtained or the identifiable part shall be covered. Photographs of gross specimens shall be marked with scale on the drawings. Pathological photos should indicate the staining method and magnification. If the chart is quoted from other journals, it should indicate the source and provide proof that the journal agrees to publish it.
1 1. unit of measurement: the provisions and writing rules of quantity, unit and symbol in GB 3100 ~ 3102-1993 "quantity and unit" shall be implemented. For details, please refer to the Application of Legal Units of Measurement in Medicine edited by the Journal of Chinese Medical Association. When the diagonal in the combined unit symbol is more than 1, it should be expressed in the form of negative power, such as ng kg-1min-1; Slant lines and negative powers in combination units should not be mixed. The legal units of measurement should be listed first in the narrative, and the old units should be written in brackets; If the same unit of measurement appears repeatedly, you can indicate the conversion coefficient between the legal and old units when it appears for the first time, and then list only the legal unit of measurement value. Parameters and their tolerances must be accompanied by units. When the unit of the parameter and its tolerance are the same, the unit can only be written 1 times. For example, "75.4 ng/L 18.2 ng/L" can be expressed as "(75.4 18.2) ng/L". The symbols of quantity are all in italics, such as the symbol of absorbance (formerly called optical density) is A, and "A" is in italics.
12. numbering: GB/T 15835- 1995 "regulations on the use of numbering in publications" shall be implemented. The century, year, year, month, day, hour, counting and measurement of the Gregorian calendar all use Arabic numerals. When there are ≥5 digits before and after the decimal point, every 3 digits are a group, and there are 1/4 Chinese characters between groups. But the ordinal number and year, page number, military serial number, instrument model and standard number are not divided. For the range and deviation of percentages, the percent sign of the preceding figures cannot be omitted, for example, 5%~95% cannot be written as 5 ~ 95%, and (50.2 0.6)% cannot be written as 50.2 0.6%. The multiplication of numerical value and size unit is written as follows: 4 cm×3 cm×5 cm, and cannot be written as 4×3×5 cm3.
13. References: The description format basically follows GB/T 77 14-2005 "Description Rules for References after Text". Using sequential coding system, records are marked with Arabic numerals in the order in which they appear in the text, and the serial numbers are placed in square brackets and arranged at the end of the text. Try to avoid quoting abstracts as a reference. Internal publications, unpublished materials, personal letters, etc. It should not be referenced as a file. If you really need to quote, you can indicate it in the corresponding place in the text. Cited documents (including the original meaning of words and expressions) must be checked with the original text, and foreign documents need to provide PubMed's PMID number. Please write Japanese characters according to Japanese regulations, and don't confuse them with Chinese characters and simplified characters. No more than 3 authors of the same document; If there are more than three people, only the first three people can be recorded, and then the words "etc." are added. According to the genre. The author's name always comes first, the foreigner's name is in the form of initials, and there is no abbreviation point after abbreviation; The names of different authors are separated by ",". Marking the document type tag after the title is a necessary description item of electronic documents, and other documents can also be marked. For file types and symbol codes of electronic file carriers, please refer to GB 3469 "File Types and File Carrier Codes". Abbreviations should be used for the names of foreign periodicals, and the format in the Medical Index shall prevail; Full name of Chinese periodicals. Each reference must record the start and end pages. Periodicals with continuous coding every year may not record the issue number.
Second, the submission requirement is 1. The manuscript should be advanced, scientific and practical. The manuscript should be true, accurate, distinctive, rigorous, concise, neat and standardized, and statistical processing should be carried out when necessary. Papers generally do not exceed 4000 words (including abstracts, charts and references); The number of words in lectures, summaries, meeting minutes and clinical pathology (examples) discussion manuscripts can be determined according to the specific circumstances; Essays, case reports, etc. No more than 2000 words. 2. Please submit your contribution through the remote management system of the Journal of Chinese Medical Association. Click on "Business Center"? Enter the remote manuscript management system of the magazine). After successful online submission, you need to send the following materials: (1) manuscript handling fee, 40 yuan for each manuscript (please be sure to indicate the manuscript number), remittance address: 1007 10, received by the editorial department of Chinese Journal of Internal Medicine, No.42 Dongsi West Street, Beijing; (2) Letter of recommendation from the unit: indicate the review opinions on the manuscript, as well as matters such as no second submission of the manuscript, no confidentiality, and no dispute over signature. , and affix the official seal; (3) printed copy (the manuscript number should also be indicated); (4) If this research is a fund project, a copy of the approval shall be attached. Please call the editorial department if you need help in the process of submission.
Iii. manuscript processing 1. This journal implements a three-trial system based on peer review (editor's first trial, expert's external trial and editorial board's final trial). At the time of submission, the author must inform the potential conflict of interest related to the research. Protect the privacy of the author's manuscript in the process of reviewing manuscripts. For manuscripts that are not ready to be published, rejection opinions will be notified. If there are different opinions on the handling of the manuscript, the author has the right to apply for reconsideration and submit a written complaint. 2. Rejection: After reviewing and sorting out the manuscript to be published initially according to the rejection opinions, in order to shorten the publication cycle and reduce errors, please send the manuscript back through the manuscript remote management system first, and send the revised manuscript printed back to the editorial department of this journal, and the author will sign it and indicate that there is no manuscript or two drafts. 3. "Fast Track" manuscript requirements: Papers that meet the requirements of "Fast Track" adopt a specific review process, and the review results of papers (published by "Fast Track" and regarded as ordinary manuscripts and rejected) will be replied within 1 month after receiving the manuscript, and papers that meet the requirements will be published within 4 months after receiving the manuscript. The "fast track" paper must be innovative, important and scientific, and its early publication will have a great impact on clinical and scientific research work. The author should contact the editorial department to explain the basic situation of the research before submitting the manuscript. After confirmation, the manuscript will be submitted in the manuscript remote management system. After successful submission, the manuscript number will be informed to the editorial department, and the paper manuscript will be sent to the editorial department by express mail. The manuscript should meet the requirements of the manuscript contract of this journal, with a letter of introduction from the unit. The author should provide written materials to explain why the paper needs to be published through the "fast track", and at the same time provide the "novelty retrieval report" issued by the provincial and above libraries or medical information research institutes. At the same time, there are two peer experts with senior titles (at least 1 is a non-unit expert) who give written recommendations. The author can recommend 3 ~ 5 peer reviewers (please indicate their detailed contact information, including email) for editing reference. The correspondence address, telephone number, e-mail and other contact information of the author shall be provided. Anyone who requests to enter the "fast track" manuscript is required to pay the review fee for each 400 yuan. Remit it to the editorial department of Chinese Journal of Internal Medicine, No.42 Dongsi West Street, Beijing, 1007 10. Please be sure to indicate "fast track audit fee" in the postscript. 4. According to "Copyright Law of People's Republic of China (PRC)" and the actual situation of this journal, any online submission that has not been dealt with clearly within 3 months after its success is still under review. If the author wants to contribute to other journals, please contact this journal first, and don't submit two manuscripts for one manuscript. Once we find two votes for one draft, we will immediately reject it; Once a manuscript is found to be dual-purpose, this journal will deal with it as follows: (1) issue a statement to revoke the paper and its repeated publication, and notify it in a series of journals of the Chinese Medical Association; (2) notify the author's unit and other scientific journals in this field.